Sequent Scientific Limited — Board Meeting, 08-08-2025: Outcome of Board Meeting

SeQuent Scientific's board approved the consolidated financial results for the quarter ended June 30, 2025. The company reported strong revenue growth, reaching ₹441.42 crore. Profit after tax attributable to owners significantly increased to ₹14.31 crore, with total comprehensive income hitting ₹42.27 crore. The quarter saw ₹1.25 crore in expenses related to the ongoing amalgamation scheme and a ₹1.82 crore gain from a land sale by an overseas subsidiary. No dividends or new fundraising plans were announced.